Amelioration of ethanol-induced liver injury in rats by nanogold flakes

Alcohol

Volumn 47, Issue 6, 2013, Pages 467-472

  Chen, Ya Ling ^a   Peng, Hsiang Chi ^a   Tan, Shan Wen ^b   Tsai, Cheng Yuh ^b   Huang, Yi Huei ^b   Wu, Hao Yu ^b   Yang, Suh Ching ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b Gold Nanotech Inc   (Taiwan)

Author keywords

Alcoholic liver disease; Inflammatory response; Nanogold flakes; Oxidative stress

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; CATALASE; CHOLESTEROL; CYTOCHROME P450 2E1; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GOLD NANOPARTICLE; NANOGOLD FLAKE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG MEGADOSE; ENZYME ACTIVITY; LIPID PEROXIDATION; LIPID STORAGE; LIVER LEVEL; LOW DRUG DOSE; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT;

RATTUS; RATTUS NORVEGICUS;

EID: 84881544034     PISSN: 07418329     EISSN: 18736823     Source Type: Journal    
DOI: 10.1016/j.alcohol.2013.05.006     Document Type: Article

References (38)

1. Albano E. Oxidative mechanisms in the pathogenesis of alcoholic liver disease. Molecular Aspects of Medicine 2008, 29:9-16.
2. Beers R.F., Sizer I.W. Aspectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. Journal of Biological Chemistry 1952, 195:133-140.
3. Cao X., Ye Y., Liu S. Gold nanoparticle-based signal amplification for biosensing. Analytical Biochemistry 2011, 417:1-16.
4. Cederbaum A.I., Lu Y., Wu D. Role of oxidative stress in alcohol-induced liver injury. Archives of Toxicology 2009, 83:519-548.
5. Chen Y.L., Chen L.J., Bair M.J., Yao M.L., Peng H.C., Yang S.S., et al. Antioxidative status of patients with alcoholic liver disease in southeastern Taiwan. World Journal of Gastroenterology 2011, 17:1063-1070.
6. Chen Y.L., Yang S.S., Peng H.C., Hsieh Y.C., Chen J.R., Yang S.C. Folate and vitamin B12 improved alcohol-induced hyperhomocysteinemia in rats. Nutrition 2011, 27:1034-1039.
7. Das S.K., Vasudevan D.M. Alcohol-induced oxidative stress. Life Sciences 2007, 81:177-187.
8. Dey A., Cederbaum A.I. Alcohol and oxidative liver injury. Hepatology 2006, 43:S63-S74.
9. Folch J., Lees M., Sloane Stanley G.H. Asimple method for the isolation and purification of total lipides from animal tissues. Journal of Biological Chemistry 1957, 226:497-509.
10. Gao B., Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011, 141:1572-1585.
11. Griffith O.W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Analytical Biochemistry 1980, 106:207-212.
12. Homberger M., Simon U. On the application potential of gold nanoparticles in nanoelectronics and biomedicine. Philosophical Transactions of the Royal Society A: Mathematical Physical and Engineering Sciences 2010, 368:1405-1453.
13. Ji C., Deng Q., Kaplowitz N. Role of TNF-alpha in ethanol-induced hyperhomocysteinemia and murine alcoholic liver injury. Hepatology 2004, 40:442-451.
14. Ki S.H., Choi J.H., Kim C.W., Kim S.G. Combined metadoxine and garlic oil treatment efficaciously abrogates alcoholic steatosis and CYP2E1 induction in rat liver with restoration of AMPK activity. Chemico-Biological Interactions 2007, 169:80-90.
15. Leonavičiene L., Kirdaite G., Bradūnaite R., Vaitkiene D., Vasiliauskas A., Zabulyte D., et al. Effect of gold nanoparticles in the treatment of established collagen arthritis in rats. Medicina (Kaunas) 2012, 48:91-101.
16. Lieber C.S. Ethanol metabolism, cirrhosis and alcoholism. Clinica Chimica Acta 1997, 257:59-84.
17. Lieber C.S., DeCarli L.M. Animal models of chronic ethanol toxicity. Methods in Enzymology 1994, 233:585-594.
18. Lin W.T., Huang C.C., Lin T.J., Chen J.R., Shieh M.J., Peng H.C., et al. Effects of beta-carotene on antioxidant status in rats with chronic alcohol consumption. Cell Biochemistry & Function 2009, 27:344-350.
19. Lu Y., Cederbaum A.I. CYP2E1 and oxidative liver injury by alcohol. Free Radical Biology and Medicine 2008, 44:723-738.
20. McMullen M.R., Pritchard M.T., Wang Q., Millward C.A., Croniger C.M., Nagy L.E. Early growth response-1 transcription factor is essential for ethanol-induced fatty liver injury in mice. Gastroenterology 2005, 128:2066-2076.
21. Miyachi Y., Yoshioka A., Imamura S., Niwa Y. Anti-oxidant effects of gold compounds. British Journal of Dermatology 1987, 116:39-46.
22. Mukherjee P., Bhattacharya R., Wang P., Wang L., Basu S., Nagy J.A., et al. Antiangiogenic properties of gold nanoparticles. Clinical Cancer Research 2005, 11:3530-3534.
23. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 1979, 95:351-358.
24. Peng Z., Borea P.A., Varani K., Wilder T., Yee H., Chiriboga L., et al. Adenosine signaling contributes to ethanol-induced fatty liver in mice. Journal of Clinical Investigation 2009, 119:582-594.
25. Petrasek J., Dolganiuc A., Csak T., Nath B., Hritz I., Kodys K., et al. Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells. Hepatology 2011, 53:649-660.
26. Pissuwan D., Niidome T., Cortie M.B. The forthcoming applications of gold nanoparticles in drug and gene delivery systems. Journal of Controlled Release 2011, 149:65-71.
27. Rüdiger H.A., Clavien P.A. Tumor necrosis factor alpha, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver. Gastroenterology 2002, 122:202-210.
28. Schaffert C.S., Duryee M.J., Hunter C.D., Hamilton B.C., DeVeney A.L., Huerter M.M., et al. Alcohol metabolites and lipopolysaccharide: roles in the development and/or progression of alcoholic liver disease. World Journal of Gastroenterology 2009, 15:1209-1218.
29. Shukla R., Bansal V., Chaudhary M., Basu A., Bhonde R.R., Sastry M. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir 2005, 21:10644-10654.
30. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Analytical Biochemistry 1969, 27:502-522.
31. Tilg H., Day C.P. Management strategies in alcoholic liver disease. Nature Clinical Practice Gastroenterology & Hepatology 2007, 4:24-34.
32. Tsai C.Y., Shiau A.L., Chen S.Y., Chen Y.H., Cheng P.C., Chang M.Y., et al. Amelioration of collagen-induced arthritis in rats by nanogold. Arthritis & Rheumatism 2007, 56:544-554.
33. Tsukuda T., Tsunoyama H., Sakurai H. Aerobic oxidations catalyzed by colloidal nanogold. Chemistry - An Asian Journal 2011, 6:736-748.
34. Upadhyayula V.K. Functionalized gold nanoparticle supported sensory mechanisms applied in detection of chemical and biological threat agents: a review. Analytica Chimica Acta 2012, 715:1-18.
35. Victor E.G., Silveira P.C., Possato J.C., da Rosa G.L., Munari U.B., de Souza C.T., et al. Pulsed ultrasound associated with gold nanoparticle gel reduces oxidative stress parameters and expression of pro-inflammatory molecules in an animal model of muscle injury. Journal of Nanobiotechnology 2012, 10:11.
36. Xia Y., Li W., Cobley C.M., Chen J., Xia X., Zhang Q., et al. Gold nanocages: from synthesis to theranostic applications. Accounts of Chemical Research 2011, 44:914-924.
37. You M., Fischer M., Deeg M.A., Crabb D.W. Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). Journal of Biological Chemistry 2002, 277:29342-29347.
38. Zhao X.J., Dong Q., Bindas J., Piganelli J.D., Magill A., Reiser J., et al. TRIF and IRF-3 binding to the TNF promoter results in macrophage TNF dysregulation and steatosis induced by chronic ethanol. Journal of Immunology 2008, 181:3049-3056.